I wonder if there isn't a market for a COVID vaccine that the inevitable variants aren't resistant to.
If you kept it to a small group of customers, it would maintain it's value and be worth $$$$ to them potentially.
If you kept it to a small group of customers, it would maintain it's value and be worth $$$$ to them potentially.
There is no better vaccine than the one for the current dominant variants. You can't really target future mutations because you don't know what the future mutations will be. You can imagine restricting the best, most current vaccine to the rich to limit escape mutations but besides the obvious ethical concerns, the virus will mutate anyways. Better vaccinate everyone with the best, because the less people infected, the less chances you give the virus to mutate.
Mass vaccination might have made it better for costs on tptb in the past. But, if that doesn't work because a sufficient amount of the population refuses to cooperate...